GI Clinical Research 2002-2003: The Year in Review

被引:9
作者
Camilleri, Michael [1 ]
机构
[1] Mayo Clin, CENTER Program, Rochester, MN 55905 USA
关键词
D O I
10.1016/S1542-3565(03)00220-9
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
This short review, presented during the Plenary Session of the AGA meeting during Digestive Disease Week 2003, highlights advances in the fields of colorectal cancer, prevention of ulcer bleeding, Helicobacter pylori and cancer risk, novel therapies of inflammatory bowel disease, treatment of chronic hepatitis B and C, and the use of imatinib in the treatment of gastrointestinal stromal cell tumors.
引用
收藏
页码:415 / 420
页数:6
相关论文
共 20 条
  • [1] Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease
    Baert, F
    Noman, M
    Vermeire, S
    Van Assche, G
    D'Haens, G
    Carbonez, A
    Rutgeerts, P
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (07) : 601 - 608
  • [2] A randomized trial of aspirin to prevent colorectal adenomas
    Baron, JA
    Cole, BF
    Sandler, RS
    Haile, RW
    Ahnen, D
    Bresalier, R
    McKeown-Eyssen, G
    Summers, RW
    Rothstein, R
    Burke, CA
    Snover, DC
    Church, TR
    Allen, JI
    Beach, M
    Beck, GJ
    Bond, JH
    Byers, T
    Greenberg, ER
    Mandel, JS
    Marcon, N
    Mott, LA
    Pearson, L
    Saibil, F
    van Stolk, RU
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (10) : 891 - 899
  • [3] Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen
    Chan, FKL
    Chung, SCS
    Suen, BY
    Lee, YT
    Leung, WK
    Leung, VKS
    Wu, JCY
    Lau, JYW
    Hui, Y
    Lai, MS
    Chan, HLY
    Sung, JJY
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (13) : 967 - 973
  • [4] Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
    Demetri, GD
    von Mehren, M
    Blanke, CD
    Van den Abbeele, AD
    Eisenberg, B
    Roberts, PJ
    Heinrich, MC
    Tuveson, DA
    Singer, S
    Janicek, M
    Fletcher, JA
    Silverman, SG
    Silberman, SL
    Capdeville, R
    Kiese, B
    Peng, B
    Dimitrijevic, S
    Druker, BJ
    Corless, C
    Fletcher, CDM
    Joensuu, H
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (07) : 472 - 480
  • [5] Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: A randomized controlled trial
    Farrell, RJ
    Alsahli, M
    Jeen, YT
    Falchuk, KR
    Peppercorn, MA
    Michetti, P
    [J]. GASTROENTEROLOGY, 2003, 124 (04) : 917 - 924
  • [6] Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
    Fried, MW
    Shiffman, ML
    Reddy, KR
    Smith, C
    Marinos, G
    Goncales, FL
    Haussinger, D
    Diago, M
    Carosi, G
    Dhumeaux, D
    Craxi, A
    Lin, A
    Hoffman, J
    Yu, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (13) : 975 - 982
  • [7] Natalizumab for active Crohn's disease.
    Ghosh, S
    Goldin, E
    Gordon, FH
    Malchow, HA
    Rask-Madsen, J
    Rutgeerts, P
    Vyhnalek, P
    Zádorová, Z
    Palmer, T
    Donoghue, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (01) : 24 - 32
  • [8] Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B
    Hadziyannis, SJ
    Tassopoulos, NC
    Heathcote, EJ
    Chang, TT
    Kitis, G
    Rizzetto, M
    Marcellin, P
    Lim, SG
    Goodman, Z
    Wulfsohn, MS
    Xiong, S
    Fry, J
    Brosgart, CL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (09) : 800 - 807
  • [9] Leukocyte Adsorptive Apheresis for the Treatment of Active Ulcerative Colitis: A Prospective, Uncontrolled, Pilot Study
    Hanai, Hiroyuki
    Watanabe, Fumitoshi
    Takeuchi, Ken
    Iida, Takayuki
    Yamada, Masami
    Iwaoka, Yasushi
    Saniabadi, Abby
    Matsushita, Isao
    Sato, Yoshihiko
    Tozawa, Kotaro
    Arai, Hajime
    Furuta, Takahisa
    Sugimoto, Ken
    Bjarnason, Ingvar
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2003, 1 (01) : 28 - 35
  • [10] Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
    Hanauer, SB
    Feagan, BG
    Lichtenstein, GR
    Mayer, LF
    Schreiber, S
    Colombel, JF
    Rachmilewitz, D
    Wolf, DC
    Olson, A
    Bao, WH
    Rutgeerts, P
    [J]. LANCET, 2002, 359 (9317) : 1541 - 1549